SHP-2 and PTP-pest induction during Rb-E2F associated apoptosis

Cellular and Molecular Biology Letters

Volumn 17, Issue 3, 2012, Pages 422-432

  Morales, Liza D ^a,c   Pena, Karina ^a   Kim, Dae Joon ^b,c   Lieman, Jonathan H ^a  

^a UNIVERSITY OF TEXAS PAN AMERICAN   (United States)

^b Department of Pharmacology ^*  (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Apoptosis; E2F 1; Focal adhesion kinase; Phosphatase; PTP 1B; PTP PEST; PTPN1; PTPN11; PTPN12; Rb; SHP 2; Tumor suppressor

Indexed keywords

FOCAL ADHESION KINASE; MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 2; RETINOBLASTOMA E2F; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA CONTENT; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 84863570315     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-012-0020-9     Document Type: Article

References (37)

1. Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C. J., Kadkhoda, K., Wiechec, E., Halayko, A. J. and Los, M. Apoptosis and cancer: mutations within caspase genes. J. Med. Genet. 46 (2009) 497-510.
2. Hanahan, D. and Weinberg, R. A. The hallmarks of cancer. Cell100 (2000) 57-70.
3. Lazzerini Denchi, E. and Helin, K. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep. 6 (2005) 661-668.
4. Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D. and Lowe, S. W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4 (2002) 859-864.
5. Putzer, B. M. E2F1 death pathways as targets for cancer therapy. J. Cell. Mol. Med. 11 (2007) 239-251.
6. Stevens, C. and La Thangue, N. B. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 412 (2003) 157-169.
7. Hallstrom, T. C. and Nevins, J. R. Balancing the decision of cell proliferation and cell fate. Cell Cycle8 (2009) 532-535.
8. Black, E. P., Hallstrom, T., Dressman, H. K., West, M. and Nevins, J. R. Distinctions in the specificity of E2F function revealed by gene expression signatures. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15948-15953.
9. Wu, Z., Zheng, S. and Yu, Q. The E2F family and the role of E2F1 in apoptosis. Int. J. Biochem. Cell Biol. 41 (2009) 2389-2397.
10. Luo, R. X., Postigo, A. A. and Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell92 (1998) 463-473.
11. Lieman, J. H., Worley, L. A. and Harbour, J. W. Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase. J. Biol. Chem. 280 (2005) 10484-10490.
12. Young, A. P., Nagarajan, R. and Longmore, G. D. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway. Oncogene22 (2003) 7209-7217.
13. Parsons, J. T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116 (2003) 1409-1416.
14. Golubovskaya, V. M., Finch, R. and Cance, W. G. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. J. Biol. Chem. 280 (2005) 25008-25021.
15. Zouq, N. K., Keeble, J. A., Lindsay, J., Valentijn, A. J., Zhang, L., Mills, D., Turner, C. E., Streuli, C. H. and Gilmore, A. P. FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J. Cell Sci. 122 (2009) 357-367.
16. Attwell, S., Roskelley, C. and Dedhar, S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene19 (2000) 3811-3815.
17. van Nimwegen, M. J. and van de Water, B. Focal adhesion kinase: a potential target in cancer therapy. Biochem. Pharmacol. 73 (2007) 597-609.
18. Halle, M., Tremblay, M. L. and Meng, T. C. Protein tyrosine phosphatases: emerging regulators of apoptosis. Cell Cycle6 (2007) 2773-2781.
19. Halle, M., Liu, Y. C., Hardy, S., Theberge, J. F., Blanchetot, C., Bourdeau, A., Meng, T. C. and Tremblay, M. L. Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response. Mol. Cell Biol. 27 (2007) 1172-1190.
20. Marin, T. M., Clemente, C. F., Santos, A. M., Picardi, P. K., Pascoal, V. D., Lopes-Cendes, I., Saad, M. J. and Franchini, K. G. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways Circ. Res. 103 (2008) 813-824.
21. Ostman, A., Hellberg, C. and Bohmer, F. D. Protein-tyrosine phosphatases and cancer. Na. t Rev. Cancer6 (2006) 307-320.
22. Shen, Y., Schneider, G., Cloutier, J. F., Veillette, A. and Schaller, M. D. Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J. Biol. Chem. 273 (1998) 6474-6481.
23. Yu, D. H., Qu, C. K., Henegariu, O., Lu, X. and Feng, G. S. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273 (1998) 21125-21131.
24. Rafiq, K., Kolpakov, M. A., Abdelfettah, M., Streblow, D. N., Hassid, A., Dell'Italia, L. J. and Sabri, A. Role of protein-tyrosine phosphatase SHP2 in focal adhesion kinase down-regulation during neutrophil cathepsin G-induced cardiomyocytes anoikis. J. Biol. Chem. 281 (2006) 19781-19792.
25. Julien, S. G., Dube, N., Hardy, S. and Tremblay, M. L. Inside the human cancer tyrosine phosphatome. Nat. Rev. Cancer11 (2011) 35-49.
26. Ma, D., Zhou, P. and Harbour, J. W. Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J. Biol. Chem. 278 (2003) 19358-19366.
27. Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., Richards, W. G., Du, J., Girard, L., Minna, J. D., Loh, M. L., Fisher, D. E., Velculescu, V. E., Vogelstein, B., Meyerson, M., Sellers, W. R. and Neel, B. G. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64 (2004) 8816-8820.
28. Mohi, M. G. and Neel, B. G. The role of Shp2 (PTPN11) in cancer. Curr. Opin. Genet. Dev. 17 (2007) 23-30.
29. Angers-Loustau, A., Cote, J. F. and Tremblay, M. L. Roles of protein tyrosine phosphatases in cell migration and adhesion. Biochem. Cell Biol. 77 (1999) 493-505.
30. Zheng, Y., Yang, W., Xia, Y., Hawke, D., Liu, D. X. and Lu, Z. Ras-induced and extracellular signal-regulated kinase 1 and 2 phosphorylation-dependent isomerization of protein tyrosine phosphatase (PTP)-PEST by PIN1 promotes FAK dephosphorylation by PTP-PEST. Mol. Cell Biol. 31 (2011) 4258-4269.
31. Thompson, L. J., Jiang, J., Madamanchi, N., Runge, M. S. and Patterson, C. PTP-epsilon, a tyrosine phosphatase expressed in endothelium, negatively regulates endothelial cell proliferation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H396-403.
32. Jiang, Z. X. and Zhang, Z. Y. Targeting PTPs with small molecule inhibitors in cancer treatment. Cancer Metastasis Rev. 27 (2008) 263-272.
33. Lessard, L., Stuible, M. and Tremblay, M. L. The two faces of PTP1B in cancer. Biochim. Biophys. Acta1804 (2010) 613-619.
34. Hubbard, S. R. and Miller, W. T. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr. Opin. Cell Biol. 19 (2007) 117-123.
35. Lemmon, M. A. and Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell141 (2010) 1117-1134.
36. Hunter, T. Tyrosine phosphorylation: thirty years and counting. Curr. Opin. Cell Biol. 21 (2009) 140-146.
37. Tonks, N. K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7 (2006) 833-846.